Tocilizumab, an anti-IL-6 receptor antibody, to treat COVID-19-related respiratory failure: a case report
Jean‐Marie Michot, Laurence Albigès, Nathalie Chaput, Véronique Saada, Fanny Pommeret, Frank Griscelli, Corinne Balleyguier, Benjamin Besse, Aurélien Marabelle, Florence Netzer, Mansouria Merad, Caroline Robert, Fabrice Barlési, Bertrand Gachot, Annabelle Stoclin
Topics & Concepts
MedicineCytokine stormImmunologyProinflammatory cytokineCytokineTumor necrosis factor alphaChemokineCoronavirusTocilizumabPathogenesisInflammationInternal medicineDiseaseCoronavirus disease 2019 (COVID-19)Rheumatoid arthritisInfectious disease (medical specialty)COVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 ResearchLong-Term Effects of COVID-19